Kinetics and Value of Hepatitis B Core-Related Antigen in Patients with Chronic Hepatitis B Virus Infection during Antiviral Treatment.

Lisa SandmannBirgit BremerValerie OhlendorfJerzy JaroszewiczHeiner WedemeyerMarkus CornbergBenjamin Maasoumy

Published in: Viruses (2024)

HBcrAg levels before antiviral treatment help to identify patients with chances of HBsAg loss or HBeAg seroconversion. However, its utility in replacing quantitative HBV DNA to evaluate treatment efficacy or virological relapse off-treatment is limited.

Keyphrases

hepatitis b virus
combination therapy
mass spectrometry
circulating tumor
drug induced